http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101587216-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 2009-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101587216-B1 |
| titleOfInvention | Extract of phaleria macrocarpa as an antineoplastic, anti-inflammatory and antiangiogenic agent |
| abstract | A pharmaceutical dosage form consisting of a Palliera macrocarpa extract with anti-neoplastic, anti-inflammatory and anti-angiogenic activity. Its use as an anti-neoplastic agent is to inhibit tumor growth. Its use as an anti-inflammatory agent is to alleviate inflammation and pain, and also has application as an antipyretic agent. Another use is as an antiangiogenic agent to inhibit the growth of new blood vessels to prevent cancer metastasis. |
| priorityDate | 2008-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 157.